Obesity is not associated with adverse outcome following surgical resection of oesophageal adenocarcinoma

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 5, 2010, Pages 604-608

  Madani, Koroush ^a   Zhao, Ronghua ^a   Lim, Hyun Ja ^a   Casson, Sharon M ^a   Casson, Alan G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adenocarcinoma; Obesity; Oesophagus; Outcome

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL APPROACH; SURGICAL MORTALITY; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBESITY; TREATMENT OUTCOME;

EID: 77957889315     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.03.054     Document Type: Article

References (25)

1. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-1389.
2. Polednak A.P. Estimating the number of US incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 2008, 32:190-199.
3. Kamat P., Wen S., Morris J., Anandasabapathy S. Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg 2009, 87:655-662.
4. Veugelers P.J., Porter G.A., Guernsey D.L., Casson A.G. Obesity and lifestyle risk factors for gastroesophageal reflux disease. Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006, 19:321-328.
5. Corley D.A., Kubo A., Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008, 17:352-358.
6. Hampel H., Abraham N.S., El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
7. Kubo A., Corley D.A. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 2006, 15:872-878.
8. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. Prospective Studies Collaboration.
9. Wigfield C.H., Lindsey J.D., Munoz A., Chopra P.S., Edwards N.M., Love R.B. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI>40. Eur J Cardiothorac Surg 2006, 29:434-440.
10. Sun X., Hill P.C., Bafi A.S., Garcia J.M., Haile E., Corso P.J., Boyce S.W. Is cardiac surgery safe in extremely obese patients (body mass index 50 or greater)?. Ann Thorac Surg 2009, 87:540-547.
11. Williams T.K., Rosato E.L., Kennedy E.P., Chojnacki K.A., Andrel J., Hyslop T., Doria C., Sauter P.K., Bloom J., Yeo C.J., Berger A.C. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 2009, 208:210-217.
12. Fleming J.B., Gonzalez R.J., Petzel M.Q., Lin E., Morris J.S., Gomez H., Lee J.E., Crane C.H., Pisters P.W., Evans D.B. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 2009, 144:216-221.
13. Healy L.A., Ryan A.M., Gopinath B., Rowley S., Byrne P.J., Reynolds J.V. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg 2007, 134:1284-1291.
14. Sundelof M., Lagergren J., Ye W. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 2008, 44:1566-1571.
15. Kilic A., Schuchert M.J., Pennathur A., Yaeger K., Prasanna V., Luketich J.D., Gilbert S. Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg 2009, 87:412-415.
16. Akinnusi M.E., Pineda L.A., El Solh A.A. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008, 36:151-158.
17. Curtis J.P., Selter J.G., Wang Y., Rathore S.S., Jovin I.S., Jadbabaie F., Kosiborod M., Portnay E.L., Sokol S.I., Bader F., Krumholz H.M. The obesity paradox. Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005, 165:55-61.
18. Madani K., Zhao R., Lim H.J., Casson A.G. Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study. Eur J Cardiothorac Surg 2010, 37:1427-1432.
19. Casson A.G., Porter G.A., Veuglers P.J. Evolution and critical appraisal of anastomotic technique following resection of esophageal adenocarcinoma. Dis Esophagus 2002, 15:296-302.
20. Fujitani K., Ajani J.A., Crane C.H., Feig B.W., Pisters P.W., Janjan N., Walsh G.L., Swisher S.G., Vaporcian A.A., Rice D., Welch A., Baker J., Faust J., Mansfield P.F. Impact of induction chemotherapy and postoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 2007, 14:2010-2017.
21. Lagergren J., Bergstrom R., Lindgren A., Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999, 340:825-831.
22. Vaninetti N.M., Geldenhuys L., Porter G.A., Risch H., Hainaut P., Guernsey D.L., Casson A.G. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Mol Carcinog 2008, 47:275-285.
23. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008, 8:205-211.
24. Macdonald K., Porter G.A., Guernsey D.L., Zhao R., Casson A.G. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. Cancer Epidemiol 2009, 33:37-40.
25. Zhao R., Macdonald K., Casson A.G. Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma. Mol Carcinog 2009, 48:982-988.